Skip to main content
OpenTrials

Clinical trial condition

Fabry Disease

Explore clinical trials studying Fabry Disease. Study availability and eligibility vary by location and protocol.

158 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Fabry Disease trial results

Completed

Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease

NCT04049760

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of South Florida Tampa, Florida, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • University of Minnesota Masonic Children's Hospital and Clinics Minneapolis, Minnesota, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View Trial Details
Completed

A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.

NCT04281537

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Amicus Therapeutics, Inc. Philadelphia, Pennsylvania, United States
  • Instituto de Genética e Erros Inatos do Metabolismo (IGEIM) São Paulo, Brazil
  • Keio University Hospital Tokyo, Japan
  • Yokohama Municipal Citizen's Hospital Yokohama, Japan
View Trial Details
Completed

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies

NCT05409846

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Centro Hospitalar Universitário de Coimbra Coimbra, Portugal
  • Hospital da Luz, Lisboa Lisbon, Portugal
  • Centro Hospitalar Universitário Lisboa Norte, EPE., Hospital de Santa Maria Lisbon, Portugal
  • Hospital Pedro Hispano (Unidade Local de Saúde Matosinhos) Matosinhos Municipality, Portugal
View Trial Details
Completed

China Post-marketing Surveillance (PMS) Study of Fabrazyme®

NCT05054387

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Investigational Site Number :1560003 Beijing, China
  • Investigational Site Number :1560002 Beijing, China
  • Investigational Site Number :1560001 Shanghai, China
  • Investigational Site Number :1560004 Shanghai, China
View Trial Details
Completed

A Study of REPLAGAL® in Treatment-naive Chinese Participants With Fabry Disease

NCT04974749

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Xiangya Hospital, Central South University Changsha, China
  • West China Hospital, Sichuan University Chengdu, China
  • The Children's Hospital of Zhejiang University School of Medicine Hangzhou, China
View Trial Details

Related conditions